1. Home
  2. FSBW vs VYGR Comparison

FSBW vs VYGR Comparison

Compare FSBW & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • VYGR
  • Stock Information
  • Founded
  • FSBW 1936
  • VYGR 2013
  • Country
  • FSBW United States
  • VYGR United States
  • Employees
  • FSBW N/A
  • VYGR N/A
  • Industry
  • FSBW Banks
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBW Finance
  • VYGR Health Care
  • Exchange
  • FSBW Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • FSBW 355.0M
  • VYGR 342.5M
  • IPO Year
  • FSBW 2012
  • VYGR 2015
  • Fundamental
  • Price
  • FSBW $41.70
  • VYGR $5.95
  • Analyst Decision
  • FSBW Hold
  • VYGR Strong Buy
  • Analyst Count
  • FSBW 1
  • VYGR 9
  • Target Price
  • FSBW $44.00
  • VYGR $16.44
  • AVG Volume (30 Days)
  • FSBW 14.6K
  • VYGR 462.5K
  • Earning Date
  • FSBW 01-22-2025
  • VYGR 11-12-2024
  • Dividend Yield
  • FSBW 2.43%
  • VYGR N/A
  • EPS Growth
  • FSBW 8.77
  • VYGR N/A
  • EPS
  • FSBW 4.68
  • VYGR 0.47
  • Revenue
  • FSBW $139,457,000.00
  • VYGR $163,784,000.00
  • Revenue This Year
  • FSBW N/A
  • VYGR N/A
  • Revenue Next Year
  • FSBW $6.26
  • VYGR N/A
  • P/E Ratio
  • FSBW $9.49
  • VYGR $13.02
  • Revenue Growth
  • FSBW 2.60
  • VYGR 3.40
  • 52 Week Low
  • FSBW $30.64
  • VYGR $5.19
  • 52 Week High
  • FSBW $49.15
  • VYGR $11.72
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 29.83
  • VYGR 46.68
  • Support Level
  • FSBW $44.37
  • VYGR $6.08
  • Resistance Level
  • FSBW $46.00
  • VYGR $6.55
  • Average True Range (ATR)
  • FSBW 1.23
  • VYGR 0.36
  • MACD
  • FSBW -0.43
  • VYGR 0.02
  • Stochastic Oscillator
  • FSBW 0.00
  • VYGR 4.41

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: